Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Disorders of the Skeletal Muscle01:28

Disorders of the Skeletal Muscle

The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Alterations in Muscle Tone ll01:12

Alterations in Muscle Tone ll

Alterations in muscle tone are common manifestations of neurological disorders and reflect dysfunction within different nervous system regions. Spasticity, paratonia, and dystonia represent distinct forms of hypertonia, each with unique mechanisms, clinical features, and diagnostic importance.CharacteristicsSpasticity happens from upper motor neuron lesions and is characterized by velocity-dependent resistance to passive movement. Clinical features include:Exaggerated deep tendon reflexesClonus...
Myasthenia Gravis ll: Pathophysiology01:22

Myasthenia Gravis ll: Pathophysiology

The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...
Myasthenia Gravis: Diagnostic Tests01:15

Myasthenia Gravis: Diagnostic Tests

Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
Chemical Synapses01:26

Chemical Synapses

Chemical synapses are specialized sites between two neurons or between a neuron and a non-neuronal cell like a muscle, glandular or sensory cell.
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Correction: Anti-correlation of KLRG1 and PD-1 expression in human tumor CD8 T cells.

Oncotarget·2026
Same author

Compassionate use efficacy of the interferon-beta inhibitor dazukibart in dermatomyositis.

Journal of the European Academy of Dermatology and Venereology : JEADV·2026
Same author

Web Alert.

Current sports medicine reports·2025
Same author

Web Alert.

Current sports medicine reports·2025
Same author

Monoclonal antibody targeting IFNβ for the treatment of NXP2-positive ulcerative juvenile dermatomyositis.

Pediatrics·2025
Same author

Web Alert.

Current sports medicine reports·2025

Related Experiment Video

Updated: Jun 16, 2026

Nerve Ultrasound Protocol to Detect Dysimmune Neuropathies
08:56

Nerve Ultrasound Protocol to Detect Dysimmune Neuropathies

Published on: October 7, 2021

Pearls: neuromuscular disorders.

Steven A Greenberg1

  • 1Harvard Medical School, Department of Neurology, Brigham and Women's Hospital, Children's Hospital Informatics Program, Boston, Massachusetts, USA. sagreenberg@partners.org

Seminars in Neurology
|February 4, 2010
PubMed
Summary

This study highlights key clinical signs for diagnosing neuromuscular disorders, differentiating conditions like neuropathies and myopathies. It emphasizes accurate identification to avoid misdiagnosis, crucial for effective patient management.

More Related Videos

Assessment of Neuromuscular Function Using Percutaneous Electrical Nerve Stimulation
07:53

Assessment of Neuromuscular Function Using Percutaneous Electrical Nerve Stimulation

Published on: September 13, 2015

Related Experiment Videos

Last Updated: Jun 16, 2026

Nerve Ultrasound Protocol to Detect Dysimmune Neuropathies
08:56

Nerve Ultrasound Protocol to Detect Dysimmune Neuropathies

Published on: October 7, 2021

Assessment of Neuromuscular Function Using Percutaneous Electrical Nerve Stimulation
07:53

Assessment of Neuromuscular Function Using Percutaneous Electrical Nerve Stimulation

Published on: September 13, 2015

Area of Science:

  • Neurology
  • Clinical Medicine

Background:

  • Accurate diagnosis of neuromuscular disorders is challenging due to overlapping symptoms.
  • Subtle clinical findings can be critical for differentiating various neuropathies and myopathies.

Purpose of the Study:

  • To present and illustrate key clinical observations for evaluating patients with neuromuscular disorders.
  • To highlight potential diagnostic pitfalls and emphasize distinguishing features of specific conditions.

Main Methods:

  • Review and illustration of clinical signs in focal neuropathies (e.g., thoracic outlet syndrome, radial neuropathy).
  • Discussion of diagnostic errors, including multifocal motor neuropathy and vasculitic neuropathy.
  • Presentation of characteristic weakness patterns in myasthenia gravis, Lambert-Eaton myasthenic syndrome, inclusion body myositis, and facioscapulohumeral muscular dystrophy.

Main Results:

  • Specific clinical signs differentiating neuropathies (e.g., scapula movement, diaphragm paralysis) are detailed.
  • Common diagnostic errors are identified, such as mistaking vasculitic neuropathy for Guillain-Barré syndrome.
  • Distinctive features of myasthenia gravis (fluctuation) and Lambert-Eaton myasthenic syndrome (nonfluctuating myopathy) are emphasized.

Conclusions:

  • Careful observation of specific clinical features is essential for accurate diagnosis of neuromuscular disorders.
  • Awareness of potential diagnostic errors can improve patient outcomes.
  • Differentiating between similar-presenting neuromuscular conditions requires a detailed understanding of their unique clinical manifestations.